Influence of amesergide treatment on the dextromethorphan test.
Baumann
P
P
Hatzinger
M
M
Hemmeter
U
U
Seifritz
E
E
Eap
C B
CB
Holsboer
E
E
D000328:Adult; D000928:Antidepressive Agents / Q000493:pharmacokinetics / Q000494:pharmacology*; D019389:Cytochrome P-450 CYP2D6; D065607:Cytochrome P-450 Enzyme Inhibitors; D003915:Dextromethorphan / Q000493:pharmacokinetics / Q000494:pharmacology*; D004873:Ergolines / Q000493:pharmacokinetics / Q000494:pharmacology*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D006899:Mixed Function Oxygenases / Q000037:antagonists & inhibitors*; D010641:Phenotype; D012702:Serotonin Antagonists / Q000493:pharmacokinetics / Q000494:pharmacology*
D000928:Antidepressive Agents; D065607:Cytochrome P-450 Enzyme Inhibitors; D004873:Ergolines; D012702:Serotonin Antagonists; D003915:Dextromethorphan; D006899:Mixed Function Oxygenases; D019389:Cytochrome P-450 CYP2D6; C066736:amesergide